Outcome of Patients with Platelet-Derived Growth Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors in the Tyrosine Kinase Inhibitor Era

Philippe Cassier (1) , Elena Fumagalli (2) , Piotr Rutkowski (3) , Patrick Schöffski (4) , Martine van Glabbeke , Maria Debiec-Rychter (5) , Jean-François Emile (6) , Florence Duffaud (7) , Javier Martin-Broto (8) , Bruno Landi (9) , Antoine Adenis (10) , François Bertucci (11) , Emmanuelle Bompas (12) , Olivier Bouché (13) , Serge Leyvraz (14) , Ian Judson , Jaap Verweij (15) , Paolo Casali (16) , Jean-Yves Blay (17) , Peter Hohenberger

1 Centre Léon Bérard [Lyon]
2 Medical Genetics Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
3 Maria Sklodowska-Curie Memorial Institute and Cancer Centre [Warsaw, Poland]
4 Department of General Medical Oncology [Leuven]
5 university of leuven
6 BECCOH - Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie
7 Neuro-Oncologie [Hôpital de la Timone - APHM]
8 Hospital Universitario Virgen del Rocío [Sevilla]
9 HEGP - Hôpital Européen Georges Pompidou [APHP]
10 Service d'Oncologie et de Gastro-Intestinale
11 CRCM - Centre de Recherche en Cancérologie de Marseille
12 CRLCC René Gauducheau
13 Hôpital Robert Debré
14 CHUV - Centre Hospitalier Universitaire Vaudois [Lausanne]
15 Erasmus MC - Erasmus University Medical Center [Rotterdam]
16 Virologie Structurale
17 Service d'Oncologie Médicale

Domains: Life Sciences [q-bio]; Cancer

Philippe Cassier, Elena Fumagalli, Piotr Rutkowski, Patrick Schöffski, Martine van Glabbeke, et al.. Outcome of Patients with Platelet-Derived Growth Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors in the Tyrosine Kinase Inhibitor Era. Clinical Cancer Research, 2012, 18 (16), pp.4458-4464. ⟨10.1158/1078-0432.ccr-11-3025⟩. ⟨hal-03623776⟩